Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Genome-Wide Association Study | 40 | 2023 | 12220 | 1.530 |
Why?
|
Genetic Loci | 11 | 2023 | 2572 | 1.370 |
Why?
|
Gene Frequency | 8 | 2023 | 3587 | 0.900 |
Why?
|
Reproduction | 2 | 2023 | 668 | 0.820 |
Why?
|
Sweden | 11 | 2023 | 1343 | 0.810 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2021 | 323 | 0.760 |
Why?
|
Quantitative Trait Loci | 5 | 2019 | 2015 | 0.760 |
Why?
|
Albumins | 1 | 2023 | 568 | 0.750 |
Why?
|
Polymorphism, Single Nucleotide | 29 | 2023 | 15494 | 0.750 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2023 | 324 | 0.680 |
Why?
|
Multifactorial Inheritance | 6 | 2023 | 1190 | 0.670 |
Why?
|
Sodium, Dietary | 1 | 2022 | 418 | 0.660 |
Why?
|
Genetic Predisposition to Disease | 22 | 2023 | 17400 | 0.650 |
Why?
|
Open Reading Frames | 2 | 2018 | 810 | 0.630 |
Why?
|
Finland | 5 | 2024 | 602 | 0.630 |
Why?
|
Homosexuality, Female | 1 | 2019 | 157 | 0.610 |
Why?
|
Biological Specimen Banks | 7 | 2022 | 707 | 0.600 |
Why?
|
Benchmarking | 1 | 2023 | 1038 | 0.570 |
Why?
|
Twins, Dizygotic | 2 | 2013 | 236 | 0.550 |
Why?
|
Twins, Monozygotic | 2 | 2013 | 458 | 0.510 |
Why?
|
Blood Banks | 1 | 2015 | 110 | 0.500 |
Why?
|
Alleles | 5 | 2021 | 6931 | 0.480 |
Why?
|
Sex Characteristics | 4 | 2022 | 2585 | 0.480 |
Why?
|
Diabetes Complications | 1 | 2021 | 1359 | 0.470 |
Why?
|
Sphingomyelins | 3 | 2019 | 105 | 0.460 |
Why?
|
Informed Consent | 1 | 2019 | 991 | 0.450 |
Why?
|
Phenotype | 14 | 2023 | 16331 | 0.430 |
Why?
|
DNA Copy Number Variations | 3 | 2018 | 1940 | 0.420 |
Why?
|
Metabolomics | 8 | 2022 | 1467 | 0.420 |
Why?
|
Coronary Disease | 5 | 2017 | 6078 | 0.410 |
Why?
|
Polymorphism, Genetic | 2 | 2022 | 4328 | 0.410 |
Why?
|
Homosexuality, Male | 1 | 2019 | 1238 | 0.400 |
Why?
|
Diabetes Mellitus, Type 2 | 10 | 2023 | 11695 | 0.400 |
Why?
|
Sexual Behavior | 1 | 2021 | 2050 | 0.390 |
Why?
|
Genome | 1 | 2019 | 1803 | 0.390 |
Why?
|
Quantitative Trait, Heritable | 1 | 2013 | 544 | 0.360 |
Why?
|
Health Care Costs | 1 | 2023 | 3203 | 0.360 |
Why?
|
Mental Disorders | 3 | 2023 | 6587 | 0.330 |
Why?
|
High-Throughput Screening Assays | 1 | 2014 | 944 | 0.330 |
Why?
|
Risk Factors | 23 | 2024 | 72145 | 0.320 |
Why?
|
Molecular Epidemiology | 3 | 2022 | 468 | 0.310 |
Why?
|
Acute Coronary Syndrome | 1 | 2021 | 2337 | 0.310 |
Why?
|
Humans | 89 | 2024 | 742088 | 0.300 |
Why?
|
Metabolome | 4 | 2022 | 881 | 0.290 |
Why?
|
Heart Defects, Congenital | 1 | 2023 | 4566 | 0.290 |
Why?
|
Genotype | 10 | 2023 | 12946 | 0.280 |
Why?
|
Risk Assessment | 8 | 2020 | 23320 | 0.260 |
Why?
|
Mutation | 4 | 2022 | 29717 | 0.260 |
Why?
|
Longevity | 1 | 2013 | 1069 | 0.250 |
Why?
|
Sample Size | 2 | 2021 | 844 | 0.250 |
Why?
|
Genome, Human | 6 | 2023 | 4420 | 0.250 |
Why?
|
Cause of Death | 1 | 2015 | 3571 | 0.250 |
Why?
|
Genetic Association Studies | 4 | 2021 | 2699 | 0.250 |
Why?
|
Insulin Resistance | 4 | 2021 | 3861 | 0.240 |
Why?
|
Male | 46 | 2023 | 349538 | 0.230 |
Why?
|
Female | 47 | 2023 | 379592 | 0.220 |
Why?
|
Aged | 28 | 2023 | 162944 | 0.220 |
Why?
|
Duty to Recontact | 1 | 2022 | 20 | 0.220 |
Why?
|
Hominidae | 1 | 2023 | 74 | 0.220 |
Why?
|
Respiratory Syncytial Viruses | 1 | 2023 | 164 | 0.220 |
Why?
|
Body Mass Index | 10 | 2023 | 12695 | 0.210 |
Why?
|
Models, Genetic | 5 | 2021 | 3493 | 0.210 |
Why?
|
2',5'-Oligoadenylate Synthetase | 1 | 2022 | 27 | 0.210 |
Why?
|
Optic Neuritis | 1 | 2024 | 166 | 0.200 |
Why?
|
Physical Chromosome Mapping | 1 | 2022 | 183 | 0.200 |
Why?
|
Insulin | 4 | 2021 | 6575 | 0.200 |
Why?
|
Mendelian Randomization Analysis | 3 | 2022 | 963 | 0.200 |
Why?
|
Genetic Variation | 6 | 2021 | 6540 | 0.190 |
Why?
|
Body Height | 3 | 2019 | 1574 | 0.190 |
Why?
|
Models, Statistical | 3 | 2023 | 5100 | 0.190 |
Why?
|
Carnitine | 2 | 2020 | 239 | 0.190 |
Why?
|
Cardiovascular Diseases | 7 | 2023 | 15108 | 0.190 |
Why?
|
DiGeorge Syndrome | 1 | 2022 | 177 | 0.190 |
Why?
|
Lipids | 3 | 2018 | 3302 | 0.190 |
Why?
|
Middle Aged | 29 | 2023 | 213127 | 0.180 |
Why?
|
Genetic Testing | 1 | 2013 | 3439 | 0.180 |
Why?
|
Urobilin | 1 | 2019 | 1 | 0.180 |
Why?
|
Cytochrome P-450 CYP1A2 | 2 | 2016 | 68 | 0.180 |
Why?
|
Chromatography, Liquid | 3 | 2020 | 977 | 0.180 |
Why?
|
Case-Control Studies | 6 | 2022 | 21719 | 0.180 |
Why?
|
Adiposity | 2 | 2022 | 1806 | 0.170 |
Why?
|
Genes, Essential | 1 | 2020 | 182 | 0.170 |
Why?
|
Chromosomes, Human | 1 | 2021 | 457 | 0.170 |
Why?
|
Urine | 1 | 2020 | 370 | 0.170 |
Why?
|
Inheritance Patterns | 1 | 2021 | 340 | 0.170 |
Why?
|
Software | 4 | 2019 | 4434 | 0.170 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2021 | 563 | 0.160 |
Why?
|
Obesity, Abdominal | 1 | 2022 | 361 | 0.160 |
Why?
|
Blood Glucose | 4 | 2021 | 6249 | 0.160 |
Why?
|
Registries | 5 | 2019 | 8077 | 0.160 |
Why?
|
Anthropometry | 2 | 2013 | 1350 | 0.160 |
Why?
|
Mutation, Missense | 2 | 2019 | 2556 | 0.160 |
Why?
|
Longitudinal Studies | 6 | 2023 | 13921 | 0.160 |
Why?
|
Fertility | 1 | 2023 | 770 | 0.160 |
Why?
|
Environmental Pollutants | 2 | 2018 | 1180 | 0.160 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2021 | 504 | 0.150 |
Why?
|
Selection, Genetic | 2 | 2023 | 914 | 0.150 |
Why?
|
Research Design | 1 | 2013 | 5979 | 0.150 |
Why?
|
Bile Acids and Salts | 2 | 2016 | 353 | 0.150 |
Why?
|
Mass Screening | 1 | 2013 | 5238 | 0.150 |
Why?
|
Disease | 1 | 2023 | 681 | 0.150 |
Why?
|
RNA Splicing | 1 | 2022 | 907 | 0.150 |
Why?
|
Incidence | 7 | 2020 | 20928 | 0.140 |
Why?
|
Causality | 1 | 2023 | 1265 | 0.140 |
Why?
|
Epilepsy, Rolandic | 1 | 2017 | 50 | 0.140 |
Why?
|
Diet, Reducing | 1 | 2020 | 461 | 0.140 |
Why?
|
Organ Specificity | 2 | 2021 | 2003 | 0.140 |
Why?
|
Glucose Intolerance | 1 | 2021 | 577 | 0.140 |
Why?
|
Waist-Hip Ratio | 4 | 2022 | 517 | 0.140 |
Why?
|
Dementia | 3 | 2023 | 2501 | 0.140 |
Why?
|
Jews | 1 | 2018 | 385 | 0.140 |
Why?
|
Hexachlorobenzene | 1 | 2015 | 30 | 0.140 |
Why?
|
Adult | 21 | 2023 | 213712 | 0.140 |
Why?
|
Alkanesulfonic Acids | 1 | 2018 | 180 | 0.140 |
Why?
|
Quality-Adjusted Life Years | 1 | 2022 | 1679 | 0.140 |
Why?
|
Molecular Sequence Annotation | 1 | 2018 | 527 | 0.140 |
Why?
|
Educational Status | 1 | 2023 | 2533 | 0.130 |
Why?
|
Dichlorodiphenyl Dichloroethylene | 1 | 2015 | 88 | 0.130 |
Why?
|
Area Under Curve | 2 | 2021 | 1653 | 0.130 |
Why?
|
Fatty Acids, Monounsaturated | 1 | 2016 | 194 | 0.130 |
Why?
|
Caffeine | 2 | 2016 | 699 | 0.130 |
Why?
|
Monoglycerides | 1 | 2014 | 10 | 0.130 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2016 | 276 | 0.130 |
Why?
|
Epilepsy, Generalized | 1 | 2017 | 174 | 0.130 |
Why?
|
Linear Models | 3 | 2014 | 5948 | 0.130 |
Why?
|
Coffea | 1 | 2014 | 22 | 0.130 |
Why?
|
Arylamine N-Acetyltransferase | 1 | 2015 | 86 | 0.130 |
Why?
|
Schizophrenia | 3 | 2022 | 6874 | 0.130 |
Why?
|
Obesity | 7 | 2020 | 12705 | 0.130 |
Why?
|
Lysophosphatidylcholines | 1 | 2014 | 81 | 0.120 |
Why?
|
Proportional Hazards Models | 3 | 2015 | 12344 | 0.120 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2016 | 209 | 0.120 |
Why?
|
Databases, Genetic | 2 | 2020 | 1780 | 0.120 |
Why?
|
Aged, 80 and over | 9 | 2022 | 57683 | 0.120 |
Why?
|
Lipoprotein(a) | 1 | 2018 | 425 | 0.120 |
Why?
|
Autistic Disorder | 1 | 2023 | 1174 | 0.120 |
Why?
|
Income | 1 | 2023 | 1904 | 0.120 |
Why?
|
Cholesterol, LDL | 4 | 2018 | 2354 | 0.120 |
Why?
|
Receptors, Odorant | 1 | 2013 | 61 | 0.110 |
Why?
|
Education | 1 | 2016 | 543 | 0.110 |
Why?
|
Epilepsies, Partial | 1 | 2017 | 436 | 0.110 |
Why?
|
Fluorocarbons | 1 | 2018 | 452 | 0.110 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 6454 | 0.110 |
Why?
|
Immunoglobulins | 1 | 2016 | 880 | 0.110 |
Why?
|
Rare Diseases | 1 | 2018 | 554 | 0.110 |
Why?
|
Pesticides | 1 | 2015 | 287 | 0.110 |
Why?
|
Discriminant Analysis | 1 | 2013 | 235 | 0.110 |
Why?
|
Predictive Value of Tests | 4 | 2023 | 15056 | 0.110 |
Why?
|
Body Weights and Measures | 1 | 2013 | 211 | 0.110 |
Why?
|
Cohort Studies | 9 | 2023 | 40450 | 0.110 |
Why?
|
Heredity | 1 | 2013 | 154 | 0.110 |
Why?
|
Epistasis, Genetic | 1 | 2015 | 365 | 0.110 |
Why?
|
Aging | 5 | 2023 | 8626 | 0.110 |
Why?
|
Phospholipids | 1 | 2016 | 781 | 0.110 |
Why?
|
Communicable Diseases | 1 | 2021 | 878 | 0.110 |
Why?
|
Chromosome Deletion | 1 | 2017 | 1400 | 0.110 |
Why?
|
Artifacts | 1 | 2021 | 1903 | 0.110 |
Why?
|
Task Performance and Analysis | 1 | 2016 | 780 | 0.100 |
Why?
|
Self Report | 1 | 2023 | 3548 | 0.100 |
Why?
|
Prognosis | 4 | 2023 | 29010 | 0.100 |
Why?
|
Cognition | 4 | 2023 | 6722 | 0.100 |
Why?
|
Child | 7 | 2023 | 77478 | 0.100 |
Why?
|
Twin Studies as Topic | 1 | 2012 | 105 | 0.100 |
Why?
|
Anorexia Nervosa | 1 | 2021 | 1286 | 0.100 |
Why?
|
Carbohydrate Metabolism | 1 | 2012 | 264 | 0.100 |
Why?
|
Menarche | 1 | 2014 | 513 | 0.100 |
Why?
|
Trace Elements | 1 | 2013 | 198 | 0.100 |
Why?
|
Glucose | 3 | 2018 | 4391 | 0.100 |
Why?
|
Algorithms | 5 | 2023 | 13853 | 0.100 |
Why?
|
Receptors, LDL | 1 | 2013 | 475 | 0.100 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2022 | 1728 | 0.100 |
Why?
|
Vaccination | 1 | 2023 | 3256 | 0.090 |
Why?
|
Genetics, Population | 3 | 2023 | 933 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1114 | 0.090 |
Why?
|
Diseases in Twins | 1 | 2012 | 450 | 0.090 |
Why?
|
Lipid Metabolism | 2 | 2016 | 1887 | 0.090 |
Why?
|
Genes | 1 | 2014 | 1892 | 0.090 |
Why?
|
Fatty Acids | 1 | 2018 | 1806 | 0.090 |
Why?
|
Periodontitis | 1 | 2015 | 553 | 0.090 |
Why?
|
Proteome | 1 | 2020 | 1790 | 0.090 |
Why?
|
Cholesterol, HDL | 2 | 2013 | 1813 | 0.090 |
Why?
|
Statistics, Nonparametric | 1 | 2016 | 2885 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2017 | 9410 | 0.090 |
Why?
|
Prospective Studies | 7 | 2019 | 53187 | 0.090 |
Why?
|
Point Mutation | 1 | 2015 | 1624 | 0.090 |
Why?
|
Magnesium | 1 | 2013 | 813 | 0.090 |
Why?
|
Pneumonia | 1 | 2021 | 2117 | 0.090 |
Why?
|
Tandem Mass Spectrometry | 3 | 2020 | 1157 | 0.080 |
Why?
|
Multiple Sclerosis | 1 | 2024 | 3076 | 0.080 |
Why?
|
Health Status | 1 | 2022 | 4030 | 0.080 |
Why?
|
Age Factors | 3 | 2021 | 18355 | 0.080 |
Why?
|
Triglycerides | 2 | 2013 | 2450 | 0.080 |
Why?
|
Weight Loss | 1 | 2020 | 2604 | 0.080 |
Why?
|
Sequence Analysis, DNA | 1 | 2019 | 4801 | 0.080 |
Why?
|
Netherlands | 1 | 2013 | 2170 | 0.080 |
Why?
|
Life Style | 3 | 2022 | 3824 | 0.080 |
Why?
|
Myocardium | 1 | 2021 | 4775 | 0.080 |
Why?
|
Proteins | 3 | 2018 | 6096 | 0.080 |
Why?
|
Germany | 2 | 2022 | 860 | 0.070 |
Why?
|
Sepsis | 1 | 2021 | 2589 | 0.070 |
Why?
|
Proteomics | 1 | 2020 | 3618 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2021 | 19862 | 0.070 |
Why?
|
Computational Biology | 1 | 2019 | 3518 | 0.070 |
Why?
|
Fasting | 3 | 2021 | 1589 | 0.070 |
Why?
|
3T3-L1 Cells | 2 | 2018 | 197 | 0.070 |
Why?
|
Antigens, CD | 1 | 2016 | 4024 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2018 | 3585 | 0.070 |
Why?
|
Membrane Glycoproteins | 1 | 2016 | 3769 | 0.070 |
Why?
|
Lipolysis | 2 | 2018 | 211 | 0.070 |
Why?
|
Brain Ischemia | 1 | 2019 | 3258 | 0.070 |
Why?
|
Kidney | 1 | 2021 | 7167 | 0.070 |
Why?
|
Liver | 1 | 2021 | 7470 | 0.070 |
Why?
|
India | 2 | 2023 | 2187 | 0.060 |
Why?
|
Linkage Disequilibrium | 2 | 2022 | 1995 | 0.060 |
Why?
|
Crohn Disease | 1 | 2018 | 2301 | 0.060 |
Why?
|
Comorbidity | 1 | 2019 | 10372 | 0.060 |
Why?
|
Glucose Tolerance Test | 2 | 2018 | 1150 | 0.060 |
Why?
|
Haplotypes | 2 | 2022 | 2781 | 0.060 |
Why?
|
Stroke | 2 | 2019 | 9963 | 0.060 |
Why?
|
Severity of Illness Index | 1 | 2022 | 15530 | 0.060 |
Why?
|
Meta-Analysis as Topic | 2 | 2023 | 1342 | 0.060 |
Why?
|
Estonia | 1 | 2023 | 53 | 0.060 |
Why?
|
Infant | 2 | 2023 | 35070 | 0.060 |
Why?
|
Motor Activity | 1 | 2013 | 2714 | 0.060 |
Why?
|
Factor V | 1 | 2023 | 174 | 0.050 |
Why?
|
C-Reactive Protein | 1 | 2014 | 3766 | 0.050 |
Why?
|
Bipolar Disorder | 1 | 2020 | 5024 | 0.050 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6891 | 0.050 |
Why?
|
Lung | 1 | 2021 | 9826 | 0.050 |
Why?
|
Smoking | 2 | 2017 | 8969 | 0.050 |
Why?
|
Depressive Disorder, Major | 1 | 2020 | 4628 | 0.050 |
Why?
|
Alzheimer Disease | 1 | 2023 | 7988 | 0.050 |
Why?
|
Follow-Up Studies | 2 | 2014 | 39004 | 0.050 |
Why?
|
Feeding Behavior | 1 | 2014 | 3187 | 0.050 |
Why?
|
Pandemics | 1 | 2022 | 8328 | 0.050 |
Why?
|
Homeostasis | 1 | 2012 | 3335 | 0.050 |
Why?
|
Gene Expression | 3 | 2021 | 7790 | 0.050 |
Why?
|
Toll-Like Receptor 7 | 1 | 2022 | 172 | 0.050 |
Why?
|
Logistic Models | 2 | 2013 | 13403 | 0.050 |
Why?
|
Inflammation | 2 | 2021 | 10578 | 0.050 |
Why?
|
Young Adult | 6 | 2021 | 56350 | 0.050 |
Why?
|
Survival Rate | 1 | 2015 | 12773 | 0.050 |
Why?
|
Parents | 1 | 2014 | 3387 | 0.050 |
Why?
|
Body Fat Distribution | 1 | 2022 | 244 | 0.050 |
Why?
|
Atlases as Topic | 1 | 2021 | 237 | 0.040 |
Why?
|
Digestive System Diseases | 1 | 2021 | 147 | 0.040 |
Why?
|
Heart Diseases | 1 | 2013 | 2789 | 0.040 |
Why?
|
Adolescent | 6 | 2022 | 85649 | 0.040 |
Why?
|
Time Factors | 3 | 2019 | 40054 | 0.040 |
Why?
|
Phagocytes | 1 | 2021 | 297 | 0.040 |
Why?
|
Mosaicism | 1 | 2021 | 440 | 0.040 |
Why?
|
Urogenital Abnormalities | 1 | 2021 | 261 | 0.040 |
Why?
|
Adaptation, Biological | 1 | 2019 | 152 | 0.040 |
Why?
|
Pulmonary Alveoli | 1 | 2021 | 675 | 0.040 |
Why?
|
Europe | 2 | 2015 | 3339 | 0.040 |
Why?
|
Autopsy | 1 | 2021 | 1006 | 0.040 |
Why?
|
Biostatistics | 1 | 2019 | 160 | 0.040 |
Why?
|
Theobromine | 1 | 2016 | 15 | 0.040 |
Why?
|
Glycerophospholipids | 1 | 2016 | 32 | 0.040 |
Why?
|
Theophylline | 1 | 2016 | 132 | 0.040 |
Why?
|
Denmark | 1 | 2019 | 736 | 0.040 |
Why?
|
Receptors, N-Methyl-D-Aspartate | 1 | 2022 | 895 | 0.040 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2018 | 315 | 0.040 |
Why?
|
Sex Factors | 2 | 2021 | 10392 | 0.030 |
Why?
|
Computer Simulation | 2 | 2023 | 6191 | 0.030 |
Why?
|
Myocardial Infarction | 1 | 2017 | 11690 | 0.030 |
Why?
|
Heart Failure | 1 | 2019 | 10856 | 0.030 |
Why?
|
Menopause | 1 | 2023 | 1621 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2021 | 24913 | 0.030 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2015 | 129 | 0.030 |
Why?
|
Chromosome Aberrations | 1 | 2021 | 1811 | 0.030 |
Why?
|
Diet | 1 | 2012 | 7923 | 0.030 |
Why?
|
Genomics | 2 | 2023 | 5692 | 0.030 |
Why?
|
Receptors, GABA-B | 1 | 2014 | 67 | 0.030 |
Why?
|
Diabetes Mellitus | 1 | 2013 | 5724 | 0.030 |
Why?
|
Potassium Channels, Tandem Pore Domain | 1 | 2014 | 58 | 0.030 |
Why?
|
Taiwan | 1 | 2015 | 496 | 0.030 |
Why?
|
Receptors, Retinoic Acid | 1 | 2014 | 232 | 0.030 |
Why?
|
Primary Health Care | 1 | 2010 | 4551 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3528 | 0.030 |
Why?
|
Language | 1 | 2023 | 1458 | 0.030 |
Why?
|
Databases, Factual | 2 | 2019 | 7716 | 0.030 |
Why?
|
RNA, Viral | 1 | 2021 | 2899 | 0.030 |
Why?
|
Genomic Imprinting | 1 | 2014 | 331 | 0.030 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2014 | 314 | 0.030 |
Why?
|
Adipogenesis | 1 | 2015 | 358 | 0.030 |
Why?
|
Regeneration | 1 | 2021 | 1485 | 0.030 |
Why?
|
Coffee | 1 | 2016 | 578 | 0.030 |
Why?
|
Viral Load | 1 | 2021 | 3292 | 0.030 |
Why?
|
Tyrosine | 1 | 2016 | 1460 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2747 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 782 | 0.030 |
Why?
|
TRPM Cation Channels | 1 | 2013 | 140 | 0.030 |
Why?
|
Hypertriglyceridemia | 1 | 2015 | 293 | 0.030 |
Why?
|
Phylogeny | 1 | 2019 | 2797 | 0.030 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 381 | 0.030 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2183 | 0.020 |
Why?
|
Brain-Derived Neurotrophic Factor | 1 | 2014 | 604 | 0.020 |
Why?
|
Fibroblasts | 1 | 2021 | 4143 | 0.020 |
Why?
|
Isoenzymes | 1 | 2015 | 1725 | 0.020 |
Why?
|
Hypothalamo-Hypophyseal System | 1 | 2014 | 703 | 0.020 |
Why?
|
Ovary | 1 | 2014 | 981 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2017 | 2203 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2017 | 2303 | 0.020 |
Why?
|
Sequence Analysis, RNA | 1 | 2017 | 2011 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8297 | 0.020 |
Why?
|
Calcium-Binding Proteins | 1 | 2014 | 1081 | 0.020 |
Why?
|
Hematologic Neoplasms | 1 | 2021 | 1820 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15194 | 0.020 |
Why?
|
Waist Circumference | 1 | 2013 | 917 | 0.020 |
Why?
|
Age Distribution | 1 | 2015 | 2900 | 0.020 |
Why?
|
DNA Methylation | 1 | 2023 | 4282 | 0.020 |
Why?
|
Biological Transport | 1 | 2013 | 2119 | 0.020 |
Why?
|
Epithelial Cells | 1 | 2021 | 3678 | 0.020 |
Why?
|
Diet Surveys | 1 | 2012 | 1172 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2021 | 3455 | 0.020 |
Why?
|
Italy | 1 | 2010 | 828 | 0.020 |
Why?
|
Cell Line | 1 | 2022 | 15994 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2015 | 7873 | 0.020 |
Why?
|
Heart | 1 | 2021 | 4462 | 0.020 |
Why?
|
Neuropsychological Tests | 1 | 2020 | 6974 | 0.020 |
Why?
|
Base Sequence | 1 | 2018 | 12797 | 0.020 |
Why?
|
Intercellular Signaling Peptides and Proteins | 1 | 2014 | 1675 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2023 | 4440 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2633 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2015 | 1368 | 0.020 |
Why?
|
Coronary Vessels | 1 | 2017 | 3099 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2020 | 13029 | 0.020 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2014 | 1860 | 0.020 |
Why?
|
Environmental Exposure | 1 | 2018 | 4231 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2014 | 2915 | 0.010 |
Why?
|
Neoplasms | 1 | 2013 | 21596 | 0.010 |
Why?
|
Hypercholesterolemia | 1 | 2010 | 1149 | 0.010 |
Why?
|
Neurons | 1 | 2022 | 9325 | 0.010 |
Why?
|
Animals | 3 | 2023 | 168561 | 0.010 |
Why?
|
Body Weight | 1 | 2013 | 4664 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2017 | 19223 | 0.010 |
Why?
|
United States | 2 | 2022 | 69693 | 0.010 |
Why?
|
Quality of Life | 1 | 2022 | 12730 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13256 | 0.010 |
Why?
|
Patient Education as Topic | 1 | 2010 | 2275 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2015 | 14554 | 0.010 |
Why?
|
Mice | 2 | 2018 | 81045 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2015 | 3428 | 0.010 |
Why?
|
Brain | 1 | 2020 | 26343 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2012 | 25575 | 0.010 |
Why?
|
Child, Preschool | 1 | 2012 | 40955 | 0.010 |
Why?
|
Breast Neoplasms | 1 | 2014 | 20774 | 0.000 |
Why?
|